Rosen Law Firm Investigates Potential Securities Claims Against Multiple Public Companies

The Rosen Law Firm is conducting investigations and litigation on behalf of shareholders of Tandem Diabetes Care, Dow Inc., and Nutex Health Inc., alleging these companies may have issued materially misleading business information impacting their stock prices. Investors who purchased securities during specific class periods may be entitled to compensation through contingency fee arrangements without any out-of-pocket costs. For Tandem Diabetes Care, the investigation follows a voluntary medical device correction announcement that caused a nearly 20% stock drop. Dow Inc. investors have an important deadline of October 28, 2025, to move the court to serve as lead plaintiff in a filed class action lawsuit. Nutex Health Inc. investors face an October 21, 2025, deadline to seek lead plaintiff status in their class action. The Rosen Law Firm highlights its experienced track record and cautions investors to choose counsel carefully, emphasizing its history of securing hundreds of millions in settlements and leadership in securities class action litigation worldwide.